[HTML][HTML] 2021 antibacterial agents in clinical and preclinical development: an overview and analysis

World Health Organization - 2022 - books.google.com
Page 1 2021 ANTIBACTERIAL AGENTS IN CLINICAL AND PRECLINICAL DEVELOPMENT:
an overview and analysis World Health Organization Page 2 A PRE Page 3 2021 …

Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital‐acquired infections: a scientific review

M Nguyen, SG Joshi - Journal of applied microbiology, 2021 - academic.oup.com
Carbapenem is an important therapy for serious hospital‐acquired infections and for the
care of patients affected by multidrug‐resistant organisms, specifically Acinetobacter …

[图书][B] 2019 antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline

World Health Organization - 2020 - books.google.com
Some rights reserved. This work is available under the Creative Commons Attribution-
NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https …

[PDF][PDF] Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, including tuberculosis

World Health Organization - 2017 - apps.who.int
The discovery of antibiotics has long been regarded as one of the most significant medical
achievements of the twentieth century. Antibiotics have saved millions of lives (1) and …

The current burden of carbapenemases: review of significant properties and dissemination among gram-negative bacteria

D Hammoudi Halat, C Ayoub Moubareck - Antibiotics, 2020 - mdpi.com
Carbapenemases are β-lactamases belonging to different Ambler classes (A, B, D) and can
be encoded by both chromosomal and plasmid-mediated genes. These enzymes represent …

Analysis of the clinical antibacterial and antituberculosis pipeline

U Theuretzbacher, S Gottwalt, P Beyer… - The Lancet Infectious …, 2019 - thelancet.com
This analysis of the global clinical antibacterial pipeline was done in support of the Global
Action Plan on Antimicrobial Resistance. The study analysed to what extent antibacterial …

Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii

CO Vrancianu, I Gheorghe, IB Czobor, MC Chifiriuc - Microorganisms, 2020 - mdpi.com
Antibiotic resistance is one of the biggest challenges for the clinical sector and industry,
environment and societal development. One of the most important pathogens responsible …

Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace

MS Ramirez, RA Bonomo, ME Tolmasky - Biomolecules, 2020 - mdpi.com
Acinetobacter baumannii is a common cause of serious nosocomial infections. Although
community-acquired infections are observed, the vast majority occur in people with …

An insight into the emergence of Acinetobacter baumannii as an oro-dental pathogen and its drug resistance gene profile–An in silico approach

JV Priyadharsini, ASS Girija, A Paramasivam - Heliyon, 2018 - cell.com
Background Acinetobacter baumannii, a potential nosocomial pathogen has stealthily
gained entry into the oral cavity. Their association with other pathogens like Pseudomonas …

Two-tiered mutualism improves survival and competitiveness of cross-feeding soil bacteria

ZB Ge, ZQ Zhai, WY Xie, J Dai, K Huang… - The ISME …, 2023 - academic.oup.com
Metabolic cross-feeding is a pervasive microbial interaction type that affects community
stability and functioning and directs carbon and energy flows. The mechanisms that underlie …